IDSA has released new guideline recommendations on the use of #ivermectin in hospitalized patients and outpatients for the Treatment & Management of Patients with COVID-19.
📄: bit.ly/3aC7TWF #COVID19Guidelines
📄: bit.ly/3aC7TWF #COVID19Guidelines
In hospitalized patients with severe COVID-19, the IDSA panel suggests against ivermectin use outside of the context of a clinical trial.
In outpatients with COVID-19, the IDSA panel suggests against ivermectin use outside of the context of a clinical trial.
In outpatients with COVID-19, the IDSA panel suggests against ivermectin use outside of the context of a clinical trial.
For evidence appraisal & rationale, please visit bit.ly/3aC7TWF.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
